SF 11

CAS No. 443292-81-7

SF 11( —— )

Catalog No. M27709 CAS No. 443292-81-7

NPY Y2 antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 48 In Stock
10MG 79 In Stock
25MG 159 In Stock
50MG 272 In Stock
100MG 421 In Stock
200MG 566 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SF 11
  • Note
    Research use only, not for human use.
  • Brief Description
    NPY Y2 antagonist.
  • Description
    NPY Y2 antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Drug Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    443292-81-7
  • Formula Weight
    446.6
  • Molecular Formula
    C27H30N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (559.79 mM)
  • SMILES
    S=C(NC(C=C1)=CC=C1OCC)N2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Markus Zollinger, et al. Absorption, distribution, metabolism, and excretion (ADME) of 1?C-sonidegib (LDE225) in healthy volunteers. Cancer Chemother Pharmacol. 2014 Jul;74(1):63-75.
molnova catalog
related products
  • CPUY074020

    CPUY074020 is a potent and orally bioavailable inhibitor of histone methyltransferase G9a (IC50: 2.18 μM) with anti-proliferative activity.

  • lorvotuzumab

    Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.

  • Reptoside

    Reptoside, which can be extracted from the roots and above-ground parts of Cortex Eucommiae and Ajuga chamaepitys (L.) Schreb, is one of the active cyclic enol ether terpene glycosides of Cortex Eucommiae for the treatment of osteoporosis.